Offer - Urjas Oil for just ₹ 1 X
Surfaz B, a prescription drug, is manufactured in various forms such as Cream. Other than this, Surfaz B has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Surfaz B is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Surfaz B have been listed ahead. These side effects of Surfaz B are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Surfaz B has a Safe effect for pregnant women and Safe effect on lactating mothers. In addition, Surfaz B's effects on the liver, heart and kidney are discussed below in the Surfaz B related warnings section.
Some other conditions that can be affected by Surfaz B are listed in the contraindications section below.
Drug interactions for Surfaz B have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Surfaz B is safe while driving, and is addiction.
Surfaz B is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Surfaz B safe for pregnant women?
Surfaz B is safe to take during pregnancy.
Is the use of Surfaz B safe during breastfeeding?
Surfaz B does not show any harmful effects in lactating women.
What is the effect of Surfaz B on the Kidneys?
Surfaz B does not damage the kidneys.
What is the effect of Surfaz B on the Liver?
Surfaz B is not harmful for the liver.
What is the effect of Surfaz B on the Heart?
Surfaz B is not harmful for the heart.
Surfaz B should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Surfaz B unless your doctor advises you to do so -
Is this Surfaz B habit forming or addictive?
Forming a habit of Surfaz B has not been reported.
Interaction between Food and Surfaz B
It is safe to take Surfaz B with food.
Interaction between Alcohol and Surfaz B
Consuming limited amounts of alcohol while taking Surfaz B does not cause any harmful effects. But it is best to observe caution.
Take Surfaz B as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
No, Use of Surfaz B does not cause any weight gain in the patient. However, if you notice any unusual weight gain then consult it with your doctor.
Surfaz B is not a pain-killer. It belongs to the class of drug called steroids. Which can help in relieving symptoms of allergy and inflammation.
Yes, long-term use of Surfaz B can raise blood pressure because Surfaz B can increase sodium levels in your body as well as fluid retention can cause increases in blood pressure.
Yes, Surfaz B is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed such as fluid retention (swelling in your hands or ankles), increased appetite, increased sweating, and stomach upset. Do not hesitate to inform your doctor if you are facing any of the above.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792